Clinical Trial Update: Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing hematologic and immunological profiles in immune thrombocytopenic purpura (ITP) exploring evolution of the disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Thrombocytopenia
• Immune Thrombocytopenic Purpura
• Thrombocytopenia

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Immune Thrombocytopenic Purpura, Autoimmune Thrombocytopenia | Phase 3 | Status: COMPLETED